IconOVir Bio snags $77m Series A
IconOVir Bio Inc., a preclinical-stage biotechnology company, has raised $77 million in Series A financing.
IconOVir Bio Inc., a preclinical-stage biotechnology company, has raised $77 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination